Charles Schwab’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-58,865
| Closed | -$290K | – | 3108 |
|
|
2016
Q4 | $290K | Buy |
58,865
+2,926
| +5% | +$14.4K | ﹤0.01% | 2859 |
|
|
2016
Q3 | $278K | Buy |
55,939
+2,458
| +5% | +$12.2K | ﹤0.01% | 2813 |
|
|
2016
Q2 | $273K | Buy |
53,481
+756
| +1% | +$3.86K | ﹤0.01% | 2818 |
|
|
2016
Q1 | $302K | Buy |
52,725
+918
| +2% | +$5.26K | ﹤0.01% | 2773 |
|
|
2015
Q4 | $538K | Sell |
51,807
-130,602
| -72% | -$1.36M | ﹤0.01% | 2614 |
|
|
2015
Q3 | $3.37M | Sell |
182,409
-4,424
| -2% | -$81.7K | 0.01% | 1742 |
|
|
2015
Q2 | $3.64M | Buy |
186,833
+146,301
| +361% | +$2.85M | 0.01% | 1756 |
|
|
2015
Q1 | $713K | Sell |
40,532
-5,230
| -11% | -$92K | ﹤0.01% | 2511 |
|
|
2014
Q4 | $732K | Buy |
45,762
+1,220
| +3% | +$19.5K | ﹤0.01% | 2474 |
|
|
2014
Q3 | $561K | Buy |
44,542
+964
| +2% | +$12.1K | ﹤0.01% | 2546 |
|
|
2014
Q2 | $681K | Buy |
43,578
+6,196
| +17% | +$96.8K | ﹤0.01% | 2503 |
|
|
2014
Q1 | $491K | Buy |
37,382
+1,140
| +3% | +$15K | ﹤0.01% | 2593 |
|
|
2013
Q4 | $583K | Buy |
36,242
+1,368
| +4% | +$22K | ﹤0.01% | 2539 |
|
|
2013
Q3 | $584K | Buy |
34,874
+1,843
| +6% | +$30.9K | ﹤0.01% | 2484 |
|
|
2013
Q2 | $334K | Buy |
+33,031
| New | +$334K | ﹤0.01% | 2691 |
|